Due to the growth of the wait-list, transplant centers have begun to consider, in addition to standard criteria donors (SCD), the use of kidneys from unconventional or high-risk donors, such as those with diabetes, hypertension, or acute kidney injury, as well as kidneys obtained through donation after cardiac death (DCD). Several studies have investigated the effects of utilizing these unconventional donor kidneys on outcomes and survival of patients with ESRD. There is some evidence suggesting that kidneys from most types of unconventional donors do provide a survival benefit. However, only DCD transplantation has become prevalent nationally in recent years. 6, 7 In the United States, the rate of DCD kidney transplant rose from 3.2% of all deceased donor transplants in 2002 to 17 .1% of all deceased donor transplants in 2014. 3, 8 While utilization of DCD kidneys may expand the pool of available donor organs, one disadvantage is the associated risk of delayed graft function (DGF). 9 DGF is most commonly defined as the need to resume or begin dialysis within seven days of transplant. A significant contributor to the increased risk of DGF after DCD kidney transplant compared to donation after brain death (DBD) kidney transplant is the duration of warm ischemia time (WIT), the time between asystole and the initiation of cold perfusion. 10, 11 While all donor organs must undergo a period of cold ischemia during transport, exposure to warm ischemia is unique to DCD organs and may diminish the organ's ability to tolerate subsequent cold ischemia. 12 Injury to a transplanted organ as a result of a period of ischemia during procurement followed by reinitiation of blood flow through the organ after the transplant is referred to as ischemia-
reperfusion injury (IRI). Studies have demonstrated that DCD kidneys/
organs are more susceptible to IRI than SCD organs.
13,14
Ischemia-reperfusion injury is a complex process that is incompletely understood. After removal of an organ from a donor, the ischemic injury is sustained when tissues are depleted of oxygen and nutrients and metabolic waste accumulates. 15 IRI is characterized as a complicated process in which multiple mechanisms appear to play a role including tissue hypoxia, oxidative injury, inflammatory response, and apoptosis. [16] [17] [18] [19] Due to impaired aerobic metabolism, heme oxygenase-1 becomes overwhelmed and iron-containing compounds collect in the cytosol. These compounds catalyze free radical-generating reactions. Following kidney transplantation, the level of inducible NOS (iNOS) has been shown to be upregulated due to IRI, 20 leading to the production high levels of nitric oxide and formation of peroxynitrite, a powerful oxidant that contributes to damage of the cytoskeleton and cell membrane and is associated with proximal tubular cell detachment. 10, 15 Other explanations for ischemic injury include decreased cellular pH and increased lytic enzyme activation due to the stimulation of anaerobic metabolism as well as reduced expression of genes that protect against ischemia in cadaveric kidneys. 15 After reperfusion, the additional injury is sustained due to stimulation of the host immune response and further production of reactive oxygen species. Proximal tubule cells release pro-inflammatory cytokines, such as IL-6 and TNF-α. 10 Increased production of other cytokines including TGF-β, IFN-γ, and IL-10 may also increase the expression of MHC class I and II molecules in the graft leading to increased allograft immunogenicity and an increased risk of acute rejection. 15, 21 Another potential contributing factor is that donor dendritic cells may respond to hypoxia and hypotension by migrating out of the allograft and into the recipient's lymphoid tissue, activating the recipient's adaptive immune system. The consequent influx of lymphocytes into the graft may cause vascular congestion, activation of the complement system and clotting cascade, and thrombosis. 10 Nitric oxide (NO), a bioactive gas produced at low levels by the constitutive NOS isoforms by several cell types including endothelial cells, has been shown to be involved in many biological functions that promote tissue perfusion and limit inflammation, which consequently provides a cytoprotective element against ischemic damages.
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Thrombospondin-1 (TSP-1) protein is a soluble ligand of the CD47 receptor that can be secreted by cells throughout the vascular system in response to hypoxia, thrombosis, and other stresses. 23 The TSP-1/ CD47 interaction results in inhibition of NO signaling via downregulating of the guanylyl cyclase activation, production of cyclic guanosine monophosphate (cGMP), and protein kinase G activation. 24 Furthermore, in mice either lacking CD47 or following anti-CD47
antibody treatment, the NO signaling pathway is enhanced resulting in reduced oxidative injury and inflammatory responses in several models of IRI. 22, 23 Blockade of the CD47 receptor also provides protection against IRI that occurs following transplantation by promoting vasodilation and improving blood flow to renal grafts as demonstrated in our previous study. CD47 blockade significantly reduced the histological damage of rat kidney transplants, promoted renal tubular cell self-renewal, 25 and consequently improved graft survival after kidney transplantation using SCD grafts. 26 In our previous studies, we also found that CD47 blockade protected both lean and steatotic rat liver grafts from IRI following liver transplantation.
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Taken together, we hypothesize that treatment of kidney grafts with antibody-mediated CD47 receptor blockade may attenuate IRI and improve the function of DCD organs after transplantation in a porcine large animal model. 
| MATERIALSANDMETHODS

| Animals
| Perioperativetreatments,procurement,and implantationofpigrenalallograftsofdonationafter cardiacdeath(DCD)
All animals were treated with buprenorphine 0.005-0.1 mg/ kg and a TKX cocktail (Telazol 4 mg/kg, ketamine 2 mg/kg, and xylazine 2 mg/kg) by intramuscular injection, intubated, and the anesthesia was maintained with 2.5% to 4% isoflurane in oxygen at a flow of 2.0 L/minute. The animals were subsequently prepared and draped sterilely, and an abdominal midline approach was used to access to the kidneys and vasculature. The core temperature of the animals were maintained around 37.5°C for the procedure.
The donor was heparinized (150 unit/kg) and the aorta was cannulated. Cardiac arrest was induced using KCl (75-100 mg/kg). After 30 minutes of warm ischemia, the kidneys were flushed with 3L
Custodial Histidine-Tryptophan-Ketoglutarate (HTK) solution (Dr.
Franz Kohler Chemie Co.) and stored at 4°C for 3.5 hours. Just prior to implantation, the grafts were flushed either with control (n = 4) or a humanized CD47mAb (clone anti-CD47 649, Tioma Therapeutics, Inc, St. Louis, n = 4) at a dosage of 10 mg per 250-300 g kidney. This dosage was derived from our previous investigation in a rodent kidney transplant model. 26 The flush was performed through the renal artery, and the effluent was flushed back through the organ five times to facilitate antibody exposure and binding to the endothelium.
For the recipient operation, a right neck incision to expose the external jugular vein was performed for the placement of a central line.
After abdominal access was obtained, the small bowel was retracted, 
| Invivoimagingstudyofthereperfusionrenal DCDgrafts
The SPY image system (NOVADAQ, Burnaby, BC, Canada) was used to assess the reperfusion of renal grafts. After the vascular anastomoses were made and before reperfusion, the recording was initiated and indocyanine green (ICG, 0.02 mg/kg) was infused through the central venous catheter followed by 10 mL of saline. The ICG was allowed to circulate for one minute, and then the clamps were released to allow reperfusion of the graft. The SPY Elite camera was suspending over the field to image blood flow into the graft for 90 seconds.
The images of grafts blood flow prior (0s) and post reperfusions at 1s, 15s, 30s, and 60s were exported, and the fluorescence density was extracted to analyze the reperfusion. The fluorescence density of the region of interest (ROI) was extracted to evaluate the grafts reperfusion after the renal vasculature were anastomosed and clamps were released using a similar method as previously reported. 29 The imaging data had 501 fluorescence density values for each pig. Data was collected on four pigs, two in the control group and two in the treatment group, over five time points (ie, 0s, 1s, 15s, 30s, and 
| Sampling,serumchemistry,enzyme-linked immunosorbentassay(ELISA)analysisandinvitro antibodybindingtoRBCs
Blood samples of the recipients were collected from day 0 to postoperative day 5. The recipient animals were euthanized on postoperative day 5 or 6, at which time, the graft was recovered, and portions were preserved in formalin or snap frozen in liquid nitrogen for further analysis. Serum creatinine, blood urea nitrogen, and potassium (1:300) for one hour at room temperature, and mounted with DAPI.
| Histologicalassessment,and immunofluorescencestainingoftherenalgrafts
Photomicrographs were taken with Zeiss Observer Z1 immunofluorescence microscope and images were captured by Axiovision 4.8.2
software (Carl Zeiss MicroImaging GmbH, Goettingen, Germany).
| Westernblottingandreal-timequantitative reversetranscriptionpolymerasechainreaction(qRT-PCR)
Protein lysis was performed at 4°C to prevent proteolytic degradation of the total proteins. Approximately 100 mg of frozen tissue was homogenized using a homogenizer three times for 10 seconds each The assay mixes of superoxide dismutase-1 (sod-1, Ss03375614_u1),
, transforming growth factor-beta (tgf-b, Ss03382325_ u1), tumor necrosis factor alpha (tnf-a, Ss03391318_g1), and GAPDH (Ss03374854_g1) were purchased from Thermo Fisher Scientific. The samples were examined in duplicate and GAPDH was used as housekeeping gene. qPCR was performed on an ABI prism 7000 machine.
In the linear range of the amplification, amplification curves were analyzed to obtain the cycle threshold (Ct) value. All genes expressions were normalized to the housekeeping gene, and fold change of expressions were calculated using delta (delta Ct) value methods.
| Statisticalanalysis
GraphPad Prism 5 software (San Diego, CA) was used to generate graphs. Data are presented as mean ± SD. Student's t-test was used to compare the differences between studying groups. P-values less than .05 were considered significant.
| RESULTS
| HumanizedCD47mAbstronglyboundtothe donorkidneytissueandincreasedthereperfusionof therenalallografts
The Landrace pig model of kidney transplantation (KTx) in bilaterally-nephrectomized recipient animals using DCD kidneys was used to investigate the effects of CD47 blockade on allograft function. We determined that 30 minutes of warm ischemia time To assess the effect of CD47 blockade on reperfusion dynamics, we used an in vivo imaging technique that uses ICG fluorescence in the blood as a measure of blood flow. 29 After the anastomoses of the graft were performed, ICG was administered intravenously, and then the vascular clamps were released. ICG fluorescence into the graft was then recorded as a video that could be analyzed (Figure 2A and Figure S1 ). A repeated measure two-way ANOVA shows that time (P < .0001), treatment (P = .0023), and interaction (P < .0001) terms were all significant, indicating that the florescence density differed by treatment group and over time, and that the difference between treatment group was not constant over time ( Figure 2B,C) . These results suggest that CD47 blockade can significantly improve graft reperfusion dynamics.
| CD47receptorblockadeimprovedDCDkidney functionandminimizedacutetubularinjuryafter transplantation
Compared to the control, the CD47mAb treatment significantly reduced the elevated serum creatinine (Cr; Day 2: 5.27 ± 0.82 vs. Figure 3C ).
| OrganstreatedwithCD47mAbhada diminishedresponsetooxidativestress
To study the effects of CD47mAb treatment on oxidative stress in renal allografts after transplantation, we analyzed the expression of several genes related to oxidative stress at either the mRNA or protein levels. As shown in Figure 4A and compared to the DCD control, 
| TheCD47mAbtherapydecreasedinflammatory responseofDCDkidneyaftertransplantation
We next assessed markers of the inflammatory response in the graft tissues. Using qRT-PCR, we found that CD47mAb treatment significantly decreased the mRNA transcription of interleukin-2 (il-2, F I G U R E 2 CD47mAb treatment resulted in more uniform and greater perfusion of DCD renal allografts. Graft blood flow prior (0s) and post reperfusions at 1s, 15s, 30s, and 60s were studied using an in vivo imaging system (n = 2/group). (A) Representative perfusion using ICG fluorescence imaging are shown at time points 0, 16, and 60 seconds after release of clamps (see Figure S1 for additional images). (B) The fluorescence density values of the region of interest (ROI) were extracted to evaluate reperfusion characteristics of the grafts. CD47mAb-treated grafts had more uniform and greater average tissue perfusion as compared to control organs. (C) The repeated measure two-way ANOVA shows that time (P < .001), treatment (P = .002), and interaction (P < .001) terms are all significant, indicating florescent density differed by treatment and over time 27.5 ± 5.0, P = .003) cells infiltration in the allografts compared with control at day 5 after KTx ( Figure 5B ).
| CD47mAbtreatmentdecreasedapoptosisand renalarchitecturalbreakdownofDCDkidneyafter transplantation
To study the severity of tissue damage of the allografts, we assessed 
| DISCUSSION
In this study, we demonstrate that CD47 blockade with a monoclonal antibody provides significant protection of renal allografts in a DCD porcine large animal model of transplantation and an increase of blood flow was measured at the early time of reperfusion in the CD47mAb treated allografts. In addition, we observed increased function (time to first urination), reduced renal injury (assessed by Cr and BUN), oxidative injury, inflammatory response, and apoptosis, and preservation of the renal architecture in the CD47mAb treated grafts compared to the controls. In this DCD model, we induced graft damage by subjecting the organs to 30 minutes of WIT after circulatory arrest. This is arguably more severe than the DCD procedure in the human setting, where the donor may have hypoxia and hypotension for a period of time, followed by 5 minutes of WIT after circulatory arrest. We had attempted to perform these studies with 60 minutes WIT, but by postoperative day 1, the serum potassium levels of control animals exceeded the allowed threshold allowed by the animal protocol and by our institutional Animal Studies Committee ( Figure S2B ). The hematocrit of animals receiving CD47mAb treated grafts trended lower, although this did not reach statistical significance ( Figure S2B ). This may be due to transient binding of the antibody to CD47 on red blood cells with subsequent clearance by the spleen. A transient anemia was also observed in rodent models using CD47 blockade with antibodies. 30 We assessed CD47mAb binding in the renal grafts immediately after cold perfusion and showed the CD47mAb strongly localized to the kidney tissue after flushing at 4°C, particularly to the glomeruli.
The retention of some antibody binding, although lower, was also observed even five days after transplantation. Because of this ability to bind at 4°C, CD47mAb may be used in conjunction with hypothermic pumping, although this would need to be tested directly to show whether there are additive benefits to using both interventions. In addition, we examined other pathways of injury in the graft tissues. CD47mAb treatment profoundly reduced the oxidative stress and inflammatory responses in the tissues after transplantation. After re-establishment of blood perfusion and oxygen delivery to the tissues, reperfusion leads to production of reactive oxygen species that has been found to initiated a cascade of deleterious cellular responses leading to inflammation, cell death, and acute kidney failure. 16 In response, the up-regulation of genes encoding antioxidant enzymes, such as superoxide dismutase-1 (sod-1), glutathione peroxidase-1 (gpx-1), and thioredoxin (txn) have been found to be increased to counteract this oxidative stress. 33, 34 We measured the magnitude of the oxidative stress response in the transplanted graft tissues and found that the ones treated with CD47mAb had significantly less evidence of oxidative stress. It has been shown that in CD47-null mice, mitochondria accumulated in a tissue-specific and age-dependent fashion that resulted in lowered reactive oxygen species production and enhanced physical performance. 24 Indeed in the present study, we found a significant down-regulation of sod-1, gpx-1, and txn mRNA levels in the CD47mAb treated the group compared to the control group, suggesting the CD47 blockade reduced oxidative stress of the DCD renal grafts and thus the need for the compensatory upregulation of the antioxidant enzymes. Hmo-1 mRNA expression was not different between the two groups which could be due to the dynamics of the oxidative stress response and our ability to assess only the day 5 time point. The serum calcium levels in the CD47 treated group were also significantly higher than in the control group, suggesting CD47mAb treatment stabilized calcium and phosphorus homeostasis possibly due to improved renal function. We also found that voltage-dependent anion-selective channel protein 1 (VDAC-1), an abundantly expressed calcium ion transport channel, 35, 36 was significantly reduced in the CD47mAb treated animals compared to the DCD control animals suggesting that calcium influx was decreased in the CD47mAb treated allografts compared to controls. Furthermore, it has been shown that increased tubular expression of Poly ADP-Ribose polymerase-1 (PARP) has been associated with delayed graft function in expanded criteria donor (ECD) human kidney allografts and in non-ECD allografts that develop posttransplant acute tubular necrosis. 37 We observed strong expression of PARP in the nucleus of both the renal tubular epithelium and glomeruli of the DCD grafts, but this expression was significantly reduced in the CD47mAb treated group as compared to the control group.
Numerous studies have shown that pro-and anti-inflammatory cytokines are released during the inflammatory response that accompanies IRI in transplanted organs. [38] [39] [40] One potential strategy for reducing IRI is to target the inflammatory cascades at their early stages. CD47 blockade has been shown to inhibit IL-12-driven Th1 cell development 41 and IL-2 response of activated naive T cells. 42 It also has been shown to suppress bacteria-induced production of IL-12, TNF-α, GM-CSF, and IL-6 by immature dendritic cells following exposure to microorganisms and limit the intensity and duration of the inflammatory response. 43 In our study, we found that the transcription of il-2, il-6, ifn-γ, and tgf-β mRNA levels, as well as the infiltration of CD4 + and CD8 + cells in the allografts were significantly reduced by CD47mAb therapy. We were not, however, able to detect changes of these cytokines in the serum after CD47mAb treatment. Together, our data and previous studies 23, 31 from other groups suggest that CD47mAb treatment may reduce the inflammatory response in the DCD kidney grafts.
Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, are endopeptidases that degrade the extracellular matrix resulting in injury to ischemic organs and inhibitors of MMPs can decrease the reperfusion injury that occurs in ischemic organs. [44] [45] [46] [47] [48] In our study, the extended warm ischemia time after circulatory arrest resulted in significant expression of MMP-2 and MMP-9.
This suggests that metalloproteinase activity was responsible, at least in part, for some of the degradation and destruction of the DCD control renal allografts. In contrast, the grafts treated with
CD47mAb had significantly decreased MMP-2 and MMP-9 expression. Furthermore, the expression of cleaved caspase-3 and Bcl-2-associated X protein (BAX) was decreased in the CD47mAb treated grafts compared to the DCD control group, showing that CD47 blockade decreases apoptosis in the kidney tissues after transplantation.
F I G U R E 6 CD47mAb treatment diminished the structural destruction of DCD allografts after transplantation. (A) Immunofluorescence staining showed a reduction of matrix metalloproteinase-2 (MMP-2) and MMP-9 in CD47mAb treated renal allografts than that in control. Western blotting (B) and densitometry analysis (C) confirmed the decreasing expression of MMP-2 and MMP-9 in renal grafts treated with CD47mAb compared to control (n = 4/group, *P < .05 or **P < .01, respectively) for five post-operative days. We were therefore unable to assess the long-term effects of CD47 blockade on factors such as chronic rejection. Also, we were unable to assess the treatment effects of CD47
blockade with higher severity IR, such as with longer donor warm ischemic times. In the human patient care setting, dialysis can be used to bridge a recipient through the recovery phase of the allograft, but this would be prohibitively difficult in the porcine model.
In summary, our data clearly demonstrates that CD47mAb therapy administered to the renal graft by flush protected the DCD renal allografts against many of the deleterious effects of ischemiareperfusion injury after transplantation, assessed both intra-operatively using in vivo organ imaging techniques and post-operatively using serum biochemical markers of renal injury. We also found molecular evidence that this improved renal function was associated with decreased oxidative injury, inflammatory response, and cell death and tissue injury.
These results support in a large animal porcine DCD model the use of 
